Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | NPY4R | P50391 | 4/20 | 0.53 |
| ▸ | NPY1R | P25929 | 3/20 | 0.53 |
| ▸ | NPY2R | P49146 | 3/20 | 0.53 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30537834 | 0.94 | TFPI (0.60) | TFPIIL23RKISS1ROPRM1OPRD1 | |
| SCHEMBL26057785 | 0.93 | TFPI (0.62) | TFPIIL23RKISS1ROPRM1OPRD1 | |
| SCHEMBL30537835 | 0.93 | NPY4R (0.60) | TFPIKISS1ROPRM1OPRD1OPRK1 | |
| SCHEMBL26057848 | 0.91 | TFPI (0.56) | TFPIIL23RKISS1RNPY4RNPY1R | |
| SCHEMBL26211953 | 0.91 | IL23R (0.54) | TFPIIL23RNPY4RNPY1RNPY2R | |
| SCHEMBL30537837 | 0.89 | NPY4R (0.59) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30176424 | 0.88 | VIPR1 (0.63) | TFPIVIPR1 | |
| SCHEMBL16508070 | 0.87 | NPY4R (0.61) | TFPIIL23RKISS1RNPY4RNPY1R | |
| SCHEMBL16508068 | 0.87 | NPY4R (0.61) | TFPIIL23RKISS1RNPY4RNPY1R | |
| SCHEMBL30484712 | 0.87 | TFPI (0.71) | TFPIIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023161311-A1 | ANTI-INFECTIVE CONJUGATE FOR USE IN THE TREATMENT OF ZIKA VIRUS INFECTION | UNIVERSITAT POMPEU FABRA (ES) | 2023-08-31 | — | — | WO | claimed |
| EP-4233917-A1 | ANTI-INFECTIVE CONJUGATE FOR USE IN THE TREATMENT OF ZIKA VIRUS INFECTION | Universitat Pompeu Fabra (ES) | 2023-08-30 | — | — | EP | claimed |
| WO-2023161311-A1 | ANTI-INFECTIVE CONJUGATE FOR USE IN THE TREATMENT OF ZIKA VIRUS INFECTION | UNIVERSITAT POMPEU FABRA (ES) | 2023-08-31 | — | — | WO | disclosed |
| EP-4233917-A1 | ANTI-INFECTIVE CONJUGATE FOR USE IN THE TREATMENT OF ZIKA VIRUS INFECTION | Universitat Pompeu Fabra (ES) | 2023-08-30 | — | — | EP | disclosed |